U.S. flag

An official website of the United States government

NM_025152.3(NUBPL):c.815-27T>C AND Mitochondrial complex 1 deficiency, nuclear type 21

Germline classification:
Conflicting interpretations of pathogenicity (7 submissions)
Last evaluated:
Jan 8, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001249675.19

Allele description [Variation Report for NM_025152.3(NUBPL):c.815-27T>C]

NM_025152.3(NUBPL):c.815-27T>C

Gene:
NUBPL:NUBP iron-sulfur cluster assembly factor, mitochondrial [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q12
Genomic location:
Preferred name:
NM_025152.3(NUBPL):c.815-27T>C
HGVS:
  • NC_000014.9:g.31850092T>C
  • NG_028349.1:g.293708T>C
  • NM_001201573.2:c.527-27T>C
  • NM_001201574.2:c.266-27T>C
  • NM_025152.3:c.815-27T>CMANE SELECT
  • NC_000014.8:g.32319298T>C
  • NM_001201573.1:c.527-27T>C
  • NM_025152.2:c.815-27T>C
  • c.815-27T-C
Links:
OMIM: 613621.0001; OMIM: 613621.0008; dbSNP: rs118161496
NCBI 1000 Genomes Browser:
rs118161496
Molecular consequence:
  • NM_001201573.2:c.527-27T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001201574.2:c.266-27T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_025152.3:c.815-27T>C - intron variant - [Sequence Ontology: SO:0001627]
Observations:
1

Condition(s)

Name:
Mitochondrial complex 1 deficiency, nuclear type 21
Synonyms:
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21
Identifiers:
MONDO: MONDO:0032625; MedGen: C4748792; OMIM: 618242

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001423626Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 15, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001736867Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Aug 24, 2020)
paternalclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001759967OMIM
no assertion criteria provided
Pathogenic
(Jul 20, 2021)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002511894Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Jul 7, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV002517825Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2019)
Pathogenic
(May 4, 2022)
germlineclinical testing

Citation Link,

SCV002768840Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Oct 19, 2020)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV003810621Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 8, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
Caucasianspaternalyes11not providednot providednot providedclinical testing

Citations

PubMed

High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency.

Calvo SE, Tucker EJ, Compton AG, Kirby DM, Crawford G, Burtt NP, Rivas M, Guiducci C, Bruno DL, Goldberger OA, Redman MC, Wiltshire E, Wilson CJ, Altshuler D, Gabriel SB, Daly MJ, Thorburn DR, Mootha VK.

Nat Genet. 2010 Oct;42(10):851-8. doi: 10.1038/ng.659. Epub 2010 Sep 5.

PubMed [citation]
PMID:
20818383
PMCID:
PMC2977978

Next-generation sequencing in molecular diagnosis: NUBPL mutations highlight the challenges of variant detection and interpretation.

Tucker EJ, Mimaki M, Compton AG, McKenzie M, Ryan MT, Thorburn DR.

Hum Mutat. 2012 Feb;33(2):411-8. doi: 10.1002/humu.21654. Epub 2011 Dec 22.

PubMed [citation]
PMID:
22072591
See all PubMed Citations (6)

Details of each submission

From Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital, SCV001423626.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

[ACMG/AMP: PS3, PP3, PP5, BS1] This alteration is supported by well-established in vitro or in vivo functional studies to have a damaging effect on protein function or splicing [PS3], is predicted to be damaging by multiple functional prediction tools [PP3], was reported as a pathogenic/likely pathogenic alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory) [PP5], has an allele frequency that is greater than expected for the associated disease [BS1].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN, SCV001736867.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Caucasians1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1paternalyesnot providedbloodnot provided1not provided1not provided

From OMIM, SCV001759967.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 sibs (patients 1A and 1B) with mitochondrial complex I deficiency nuclear type 21 (MC1DN21; 618242), Kimonis et al. (2021) identified compound heterozygosity for 2 mutations in the NUBPL gene: a c.815-27T-C transition (c.815-27T-C, NM_025152.3) in intron 9, predicted to cause splicing abnormalities, and a c.311T-C transition, resulting in a leu104-to-pro (L104P; 613621.0009) substitution. The mutations were identified by whole-exome sequencing, and the parents were shown to be mutation carriers. The L104P was reported in the gnomAD database at an allele frequency of 0.00023, and the c.815-27T-C mutation was reported in the gnomAD database at an allele frequency of 0.004476. The allele with the c.815-27T-C mutation was shown not to have the G56R mutation in cis (see 613621.0001), as had been seen in prior patients with the c.815-27T-C mutation. Splicing analysis in whole blood from the sibs showed that the c.815-27T-C mutation resulted in abnormal transcripts, with the 2 most abundant abnormal transcripts containing partial inclusion of intron 9 or skipping of exon 10. Expression of NUBPL with the L104P mutation in yeast showed that it resulted in decreased complex I levels compared to controls.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002511894.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: NUBPL c.815-27T>C is located at a position not widely known to affect splicing. 4/4 computational tools predict no significant impact on normal splicing. However, at least two publications report experimental evidence that this variant affects mRNA splicing (Tucker_2012, Kimonis_2021). The variant allele was found at a frequency of 0.0034 in 248676 control chromosomes in the gnomAD database, including 10 homozygotes. c.815-27T>C has been reported in the literature in multiple individuals affected with Mitochondrial Complex 1 Deficiency, Nuclear Type 21 (Calvo_2010, Kevelam_2013, Kimonis_2021), and some were reported as compound heterozygous with other (likely) pathogenic variants. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein expression, finding that a heterozygous control with the variant exhibited far lower expression of NUBPL protein (Tucker_2012). The following publications have been ascertained in the context of this evaluation (PMID: 20818383, 23553477, 22072591, 32518176). 11 submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic/likely pathogenic (n=8) or uncertain significance (n=3). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mendelics, SCV002517825.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002768840.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 3B-VUS. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0210 - Splice site variant (canonical or non-canonical) proven to affect splicing/expression of the transcript with a known effect on protein structure. Functional studies showed three alternate transcripts were generated as a result of aberrant splicing from the allele with this variant: one transcript with normal splicing, one with exon 10 skipped resulting in a frameshift but no nonsense-mediated decay (NMD), and a third transcript that utilised a cryptic splice site resulting in a frameshift and NMD (PMIDs: 22072591, 32518176). (P) 0251 - Variant is heterozygous. (N) 0305 - Variant is present in gnomAD >=0.01 and <0.03 for a recessive condition (972 heterozygotes, 10 homozygotes). (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0803 - Low previous evidence of pathogenicity in unrelated individuals. An allele harbouring this variant in cis with a second variant (p.(Gly56Arg)) has been reported as pathogenic in many patients, majority of whom were in compound heterozygous state with a pathogenic allele (PMIDs: 22072591, 25245479, 23553477). However, an allele harbouring this variant without the p.(Gly56Arg) variant has been associated with disease in one family (PMID: 32518176). (P) 1001 - Strong functional evidence supporting abnormal protein function. Functional studies showed levels of NUBPL mRNA and protein were decreased in the fibroblast cells heterozygous for this variant alone (PMID: 22072591). (P) 1205 - Variant is maternally inherited. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV003810621.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024